keyword
https://read.qxmd.com/read/38623840/development-of-wafer-scale-multifunctional-nanophotonic-neural-probes-for-brain-activity-mapping
#21
REVIEW
Fu Der Chen, Ankita Sharma, David A Roszko, Tianyuan Xue, Xin Mu, Xianshu Luo, Hongyao Chua, Patrick Guo-Qiang Lo, Wesley D Sacher, Joyce K S Poon
Optical techniques, such as optogenetic stimulation and functional fluorescence imaging, have been revolutionary for neuroscience by enabling neural circuit analysis with cell-type specificity. To probe deep brain regions, implantable light sources are crucial. Silicon photonics, commonly used for data communications, shows great promise in creating implantable devices with complex optical systems in a compact form factor compatible with high volume manufacturing practices. This article reviews recent developments of wafer-scale multifunctional nanophotonic neural probes...
April 16, 2024: Lab on a Chip
https://read.qxmd.com/read/38619822/sodium-glucose-cotransporter-2-inhibitors-vs-sulfonylureas-for-gout-prevention-among-patients-with-type-2-diabetes-receiving-metformin
#22
JOURNAL ARTICLE
Natalie McCormick, Chio Yokose, Na Lu, Deborah J Wexler, J Antonio Aviña-Zubieta, Mary A De Vera, Rozalina G McCoy, Hyon K Choi
IMPORTANCE: Sodium-glucose cotransporter type 2 inhibitors (SGLT2i) are a revolutionary treatment for type 2 diabetes (T2D) with cardiovascular, kidney, and serum urate-lowering benefits. OBJECTIVE: To compare risk of incident gout and rate of recurrent flares between patients with T2D initiating SGLT2i vs sulfonylurea, most common second-line glucose-lowering therapy, when added to metformin monotherapy. DESIGN, SETTING, AND PARTICIPANTS: This sequential, propensity score-matched, new-user comparative effectiveness study using target trial emulation framework included adults with T2D receiving metformin monotherapy in a Canadian general population database from January 1, 2014, to June 30, 2022...
April 15, 2024: JAMA Internal Medicine
https://read.qxmd.com/read/38617845/precision-medicine-in-the-era-of-genetic-testing-microsatellite-instability-evolved
#23
REVIEW
Dina Ioffe, Michelle McSweeny, Michael J Hall
The recognized importance of microsatellite instability (MSI) in cancer has evolved considerably in the past 30 years. From its beginnings as a molecular predictor for Lynch syndrome, MSI first transitioned to a universal screening test in all colorectal and endometrial cancers, substantially increasing the identification of patients with Lynch syndrome among cancer patients. More recently, MSI has been shown to be a powerful biomarker of response to immune checkpoint blockade therapy across a diversity of tumor types, and in 2017 was granted Food and Drug Administration approval as the first tumor histology-agnostic biomarker for a cancer therapy...
May 2024: Clinics in Colon and Rectal Surgery
https://read.qxmd.com/read/38617334/cas9-rnp-physiochemical-analysis-for-enhanced-crispr-aunp-assembly-and-function
#24
Daniel D Lane, Karthikeya S V Gottimukkala, Rachel A Cunningham, Shirley Jwa, Molly E Cassidy, Jack M P Castelli, Jennifer E Adair
CRISPR therapy for hematological disease has proven effective for transplant dependent beta thalassemia and sickle cell anemia, with additional disease targets in sight. The success of these therapies relies on high rates of CRISPR-induced double strand DNA breaks in hematopoietic stem and progenitor cells (HSPC). To achieve these levels, CRISPR complexes are typically delivered by electroporation ex vivo which is toxic to HSPCs. HSPCs are then cultured in stimulating conditions that promote error-prone DNA repair, requiring conditioning with chemotherapy to facilitate engraftment after reinfusion...
April 2, 2024: bioRxiv
https://read.qxmd.com/read/38611047/immunotherapy-for-thymomas-and-thymic-carcinomas-current-status-and-future-directions
#25
REVIEW
Arun Rajan, Alisa K Sivapiromrat, Meredith J McAdams
Thymic epithelial tumors are a histologically diverse group of cancers arising from the epithelial compartment of the thymus. These tumors are characterized by a low tumor mutation burden, a lack of actionable genomic changes, and, especially with thymomas, defects in immune tolerance. Surgery is the mainstay of the management of resectable disease, whereas advanced, unresectable tumors are treated with platinum-based chemotherapy. Disease recurrence can occur months to years after frontline treatment. Although several options are available for conventional treatment of recurrent thymic tumors, response rates are generally low, and treatment-related toxicity can affect quality of life...
March 30, 2024: Cancers
https://read.qxmd.com/read/38610873/the-role-of-telemedicine-in-children-with-obstructive-sleep-apnea-syndrome-osas-a-review-of-the-literature
#26
REVIEW
Luisa Rizzo, Elena Barbetta, Flaminia Ruberti, Matilde Petz, Marco Tornesello, Michela Deolmi, Valentina Fainardi, Susanna Esposito
The advent of telemedicine marked a significant turning point in the healthcare landscape, introducing a revolutionary approach to the delivery of medical care. Digital technologies easily connect health professionals and patients, overcoming geographical and temporal barriers. Telemedicine has been used for sleep disorders including obstructive sleep apnea syndrome (OSAS) since the mid-1990s. In adult patients with OSAS, telemedicine is helpful both for consultation and diagnosis, the latter obtained through remote recordings of oxygen saturation and further parameters registered with telemonitored respiratory polygraphy or polysomnography...
April 4, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38609561/tumor-targeted-protac-prodrug-nanoplatform-enables-precise-protein-degradation-and-combination-cancer-therapy
#27
JOURNAL ARTICLE
Zhi-Feng Zou, Lei Yang, Hui-Jun Nie, Jing Gao, Shu-Min Lei, Yi Lai, Fan Zhang, Ernst Wagner, Hai-Jun Yu, Xiao-Hua Chen, Zhi-Ai Xu
Proteolysis targeting chimeras (PROTACs) have emerged as revolutionary anticancer therapeutics that degrade disease-causing proteins. However, the anticancer performance of PROTACs is often impaired by their insufficient bioavailability, unsatisfactory tumor specificity and ability to induce acquired drug resistance. Herein, we propose a polymer-conjugated PROTAC prodrug platform for the tumor-targeted delivery of the most prevalent von Hippel-Lindau (VHL)- and cereblon (CRBN)-based PROTACs, as well as for the precise codelivery of a degrader and conventional small-molecule drugs...
April 12, 2024: Acta Pharmacologica Sinica
https://read.qxmd.com/read/38608977/exploring-fgfr-signaling-inhibition-as-a-promising-approach-in-breast-cancer-treatment
#28
REVIEW
Yan Peng, Pengfei Zhang, Wuxuan Mei, Changchun Zeng
As our grasp of cancer genomics deepens, we are steadily progressing towards the domain of precision medicine, where targeted therapy stands out as a revolutionary breakthrough in the landscape of cancer therapeutics. The fibroblast growth factor receptors (FGFR) pathway has been unveiled as a fundamental instigator in the pathophysiological mechanisms underlying breast carcinoma, paving the way for the exhilarating development of precision-targeted therapeutics. In the pursuit of exploring inhibitors that specifically target the FGFR signaling pathways, a multitude of kinase inhibitors targeting FGFR has been assiduously engineered to address the heterogeneous landscape of human malignancies...
April 10, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38604287/precision-nanomedicine-to-treat-non-small-cell-lung-cancer
#29
REVIEW
Akanksha Dessai, Usha Yogendra Nayak, Yogendra Nayak
Lung cancer is a major cause of death worldwide, being often detected at a later stage due to the non-appearance of early symptoms. Therefore, specificity of the treatment is of utmost importance for its effective treatment. Precision medicine is a personalized therapy based on the genomics of the patient to design a suitable drug approach. Genetic mutations render the tumor resistant to specific mutations and the therapy is in vain even though correct medications are prescribed. Therefore, Precision medicine needs to be explored for the treatment of Non-small cell lung cancer (NSCLC)...
April 10, 2024: Life Sciences
https://read.qxmd.com/read/38604222/atopic-keratoconjunctivitis-pathophysiology-clinic-and-potential-new-therapeutic-concepts
#30
JOURNAL ARTICLE
Thabo Lapp, Caroline Mann, Thilo Jakob, Thomas Reinhard, Philip Christian Maier
Atopic dermatitis (AD) is a chronic recurrent inflammatory skin disease with a bipolar age distribution in childhood, adolescence and middle adulthood. Up to 50% of AD patients show ocular involvement, which can be potentially sight threatening. Clinically, the majority of cases present with atopic blepharo(kerato)conjunctivitis or atopic keratoconjunctivitis (AKC); other clinical variants from this group of inflammatory ocular surface diseases are keratoconjunctivitis vernalis in childhood and adolescence and allergic conjunctivitis...
April 11, 2024: Klinische Monatsblätter Für Augenheilkunde
https://read.qxmd.com/read/38603586/commercializable-naphthalene-diimide-anolytes-for-neutral-aqueous-organic-redox-flow-batteries
#31
JOURNAL ARTICLE
Xu Liu, Heng Zhang, Chenjing Liu, Zengrong Wang, Xuri Zhang, Haiyan Yu, Yujie Zhao, Ming-Jia Li, Yinshi Li, Ya-Ling He, Gang He
Neutral aqueous organic redox flow batteries (AORFBs) hold the potential to facilitate the transition of renewable energy sources from auxiliary to primary energy, the commercial production of anolyte materials still suffers from insufficient performance of high-concentration and the high cost of the preparation problem. To overcome these challenges, this study provides a hydrothermal synthesis methodology and introduces the charged functional groups into hydrophobic naphthalene diimide cores, and prepares a series of high-performance naphthalene diimide anolytes...
April 11, 2024: Angewandte Chemie
https://read.qxmd.com/read/38602436/a-new-generation-base-editor-with-an-expanded-editing-window-for-microbial-cell-evolution-in-vivo-based-on-crispr%C3%A2-cas12b-engineering
#32
JOURNAL ARTICLE
Wenliang Hao, Wenjing Cui, Zhongmei Liu, Feiya Suo, Yaokang Wu, Laichuang Han, Zhemin Zhou
Base editors (BEs) are widely used as revolutionary genome manipulation tools for cell evolution. To screen the targeted individuals, it is often necessary to expand the editing window to ensure highly diverse variant library. However, current BEs suffer from a limited editing window of 5-6 bases, corresponding to only 2-3 amino acids. Here, by engineering the CRISPR‒Cas12b, the study develops dCas12b-based CRISPRi system, which can efficiently repress gene expression by blocking the initiation and elongation of gene transcription...
April 11, 2024: Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
https://read.qxmd.com/read/38601793/low-power-soft-transistors-triggering-revolutionary-electronics
#33
REVIEW
Ziyang Liu, Yaoshen Zhao, Zhigang Yin
No abstract text is available yet for this article.
May 6, 2024: The innovation
https://read.qxmd.com/read/38599562/3d-printing-technology-and-its-revolutionary-role-in-stent-implementation-in-cardiovascular-disease
#34
REVIEW
Muhammad Amir Khan, Niyamat Khan, Muneeb Ullah, Shah Hamayun, Nurullo Ismoilovich Makhmudov, Raziya Mbbs, Mishal Safdar, Ayisha Bibi, Abdul Wahab, Muhammad Naeem, Nurhasni Hasan
Cardiovascular disease (CVD), exemplified by coronary artery disease (CAD), is a global health concern, escalating in prevalence and burden. The etiology of CAD is intricate, involving different risk factors. CVD remains a significant cause of mortality, driving the need for innovative interventions like percutaneous coronary intervention and vascular stents. These stents aim to minimize restenosis, thrombosis, and neointimal hyperplasia while providing mechanical support. Notably, the challenges of achieving ideal stent characteristics persist...
April 8, 2024: Current Problems in Cardiology
https://read.qxmd.com/read/38596582/pioneering-microsurgery-services-in-low-income-countries-insights-from-a-plastic-surgeon-s-experience-in-ethiopia
#35
JOURNAL ARTICLE
Zenebe T Gebremariyam, Nebiyat A Weldemichael
BACKGROUND: Microsurgery, a revolutionary tool in reconstructive procedures, has historically faced challenges in implementation within resource-limited settings. This article presents the journey of establishing microsurgery services at Jimma University Medical Center (JUMC) in Ethiopia, a nation where a significant portion of the population lacks access to microsurgery. The objective was to provide a guide for establishing a microsurgery center in resource-limited settings and share experiences, challenges, and successes encountered during the establishment of the microsurgery unit at JUMC...
April 2024: Plastic and Reconstructive Surgery. Global Open
https://read.qxmd.com/read/38596419/seeing-beyond-words-the-revolutionary-role-of-chatgpt-vision-in-research-and-publication
#36
JOURNAL ARTICLE
Som S Biswas
No abstract text is available yet for this article.
April 2024: Journal of Pediatric Pharmacology and Therapeutics: JPPT: the Official Journal of PPAG
https://read.qxmd.com/read/38595379/role-of-artificial-intelligence-ai-in-dentistry-a-literature-review
#37
REVIEW
Shibani Chakravorty, Basant Kaur Aulakh, Malabika Shil, Mayuri Nepale, Rahul Puthenkandathil, Wali Syed
Artificial intelligence (AI) refers to the ability of machines to execute tasks that traditionally require human intelligence. Healthcare AI is evolving and has a highly promising future. The main uses in dentistry are patient management, diagnosis and treatment planning, and administrative tasks. Consequently, this AI system facilitates the acquisition of familiarity with this technology for every dentist, as it possesses the potential to synergistically complement forthcoming revolutionary advancements in the field of dentistry...
February 2024: Journal of Pharmacy & Bioallied Sciences
https://read.qxmd.com/read/38594878/facile-construction-of-gefitinib-loaded-zeolitic-imidazolate-framework-nanocomposites-for-the-treatment-of-different-lung-cancer-cells
#38
JOURNAL ARTICLE
Kalaivani Aiyasamy, Malathi Ramasamy, Abdurahman Hajinur Hirad, Palanisamy Arulselvan, Ravindran Jaganathan, Jagadeesh Suriyaprakash, Indumathi Thangavelu, Abdullah A Alarfaj
Gefitinib (GET) is a revolutionary targeted treatment inhibiting the epidermal growth factor receptor's tyrosine kinase action by competitively inhibiting the ATP binding site. In preclinical trials, several lung cancer cell lines and xenografts have demonstrated potential activity with GET. Response rates neared 25% in preclinical trials for non-small cell lung cancer. Here, we describe the one-pot synthesis of GET@ZIF-8 nanocomposites (NCs) in pure water, encapsulating zeolitic imidazolate framework 8 (ZIF-8)...
April 9, 2024: Biotechnology and Applied Biochemistry
https://read.qxmd.com/read/38594618/combined-therapy-of-dabrafenib-and-an-anti-her2-antibody-drug-conjugate-for-advanced-braf-mutant-melanoma
#39
JOURNAL ARTICLE
Weisong Li, Chao Zheng, Xi Xu, Yujie Xia, Kai Zhang, Ao Huang, Xinyu Zhang, Yong Zheng, Guofang Chen, Shuyong Zhang
BACKGROUND: Melanoma is the most lethal skin cancer characterized by its high metastatic potential. In the past decade, targeted and immunotherapy have brought revolutionary survival benefits to patients with advanced and metastatic melanoma, but these treatment responses are also heterogeneous and/or do not achieve durable responses. Therefore, novel therapeutic strategies for improving outcomes remain an unmet clinical need. The aim of this study was to evaluate the therapeutic potential and underlying molecular mechanisms of RC48, a novel HER2-target antibody drug conjugate, either alone or in combination with dabrafenib, a V600-mutant BRAF inhibitor, for the treatment of advanced BRAF-mutant cutaneous melanoma...
April 10, 2024: Cellular & Molecular Biology Letters
https://read.qxmd.com/read/38592580/irrigation-intelligence-enabling-a-cloud-based-internet-of-things-approach-for-enhanced-water-management-in-agriculture
#40
JOURNAL ARTICLE
Yousif Al Mashhadany, Hamid R Alsanad, Mohanad A Al-Askari, Sameer Algburi, Bakr Ahmed Taha
Advanced sensor technology, especially those that incorporate artificial intelligence (AI), has been recognized as increasingly important in various contemporary applications, including navigation, automation, water under imaging, environmental monitoring, and robotics. Data-driven decision-making and higher efficiency have enabled more excellent infrastructure thanks to integrating AI with sensors. The agricultural sector is one such area that has seen significant promise from this technology using the Internet of Things (IoT) capabilities...
April 9, 2024: Environmental Monitoring and Assessment
keyword
keyword
166967
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.